CIDRAP newsletters options
Study reveals disparities in access to sites—and thus antivirals—with 15% living more than an hour away.
Southeast Asia and the Western Pacific saw modest rises, but cases are down worldwide.
An observational study published this week in eClinicalMedicine suggests that COVID-19–related acute kidney injury (AKI) is tied to a greater risk of death, and that severe AKI may lead to poor recovery of kidney function.
At a World Health Organization (WHO) briefing today, Director-General Tedros Adhanom Ghebreyesus, PhD, said Uganda's government is making progress in its battle against Ebola, but he raised concerns about case detections outside the main hot spots.
Myocarditis and pericarditis are rare after COVID vaccination, but rates were twofold to threefold higher after receipt of the second dose of the Moderna vaccine than after the Pfizer version.
A study of US patients aged 0 to 20 years hospitalized for COVID-19 or multisystem inflammatory syndrome in children (MIS-C) in 2020 and 2021 shows that 22% had a neurologic condition, including 9% with life-threatening illness.
A clinical trial conducted in seven countries found that two shortened, bedaquiline-containing regimens had superior efficacy in treating rifampicin-resistant tuberculosis (TB) compared with a 9-month injectable-containing regimen, with fewer cases of hearing loss, investigators reported today in The Lancet.
With Arizona, Mississippi, and South Carolina now affected, poultry losses will soon set a record.
Those taking Paxlovid had a 25% lower risk of developing 10 of 12 long-COVID conditions.
Selective serotonin reuptake inhibitors (SSRIs), the most commonly used class of antidepressants in the United States, don't appear to prevent severe COVID-19 or death among outpatients, according to a study presented this week at the American Heart Association's Scientific Sessions in Chicago.
A study of electronic health record (EHR) data from a US hospital network found that more than a third of antibiotic prescriptions for uncomplicated urinary tract infections (uUTIs) were inappropriate or suboptimal, researchers reported late last week in Antimicrobial Resistance and Infection Control.
Black children made up 47% of the 83 pediatric patients, with Latinos making up 35%.
Neutralizing antibodies were about fourfold higher than with Pfizer's original COVID vaccine.
Muliple respiratory viruses are already straining health systems, with children among the hardest hit groups.
Our weekly wrap-up of antimicrobial stewardship & antimicrobial resistance scans
In a new study in BMC Medicine, Dutch researchers report that, 12 months after illness onset, people with initially moderate to severe COVID-19 still had impaired health-related quality of life (HRQL), but the same was not true for mild COVID-19.
A study of hospitalized COVID-19 patients in Michigan found that procalcitonin (PCT) trends were associated with the decision to initiate antibiotics and duration of treatment, independent of bacterial pneumonia (bPNA) status, researchers reported today in Infection Control & Hospital Epidemiology.
One report details a massive NYC effort to probe 941,035 COVID-19 cases and follow up with their contacts.
An investigational antibiotic for uncomplicated urinary tract infections met trial goals.
Data show 53% of infections are transmitted 1 to 4 days before symptoms appear.
